Alembic Pharma gets US FDA nod for cancer treatment drug Nelarabine
Alembic Pharmaceuticals said that it has received final approval from the US Food & Drug Administration (US FDA) for its abbreviated new drug application (ANDA) for Nelarabine Injection.